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Asphyxial cardiac arrest is more common among children than in adults, and pediatric cardiac ar-
rests result from gradual deterioration due to respiratory failure or sepsis rather than arrhythmic 
or structural disease itself.1 Approximately 5% to 15% of all in-hospital and out-of-hospital pedi-
atric cardiac arrests exhibit ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) at 
the time of diagnosis.2 Approximately 25% of in-hospital cardiac arrests exhibit VF or pulseless 
VT, and the frequency of these patterns increases with age.3 Therefore, it has been suggested that 
each hospital organize and maintain an acute response system or rapid response team to improve 
the treatment of in-hospital cardiac arrest.4
BASIC LIFE SUPPORT CONSIDERATIONS FOR PEDIATRIC  
ADVANCED LIFE SUPPORT
1. Collaborative management using a team approach
It is important to build an efficient team of healthcare professionals that provides advanced life 
support during cardiopulmonary resuscitation (CPR). The following factors are important in order 
for these teams to effectively perform CPR: Chest compressions should be performed immediately 
after the need for CPR has been established, and ventilation should be performed if there is a sec-
ond rescuer. Breathing is also important for infants or children, and compression-ventilation CPR, 
rather than compression-only CPR, should be performed inside hospitals. Although the prepara-
tion of a ventilation device can delay effective ventilation in some cases, chest compressions 
should be performed immediately for both infants and children. High-quality CPR is critical to 
successful pediatric advanced life support (PALS), and is defined as starting CPR within 10 sec-
onds after identifying the cardiac arrest, an adequate compression rate, an adequate compression 
depth, complete recoil of the chest wall, minimal interruptions in the compressions, a sufficient 
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chest expansion during the ventilation, and the avoidance of hy-
perventilation. If two rescuers are performing chest compressions 
and breathing, the third rescuer (if available) should prepare a 
monitor and defibrillator, establish the medication route(s), and 
calculate the medication dosage(s). When several rescuers perform 
CPR, the rescuers should clearly communicate their roles using 
precise and respectful expressions.
2. Patients on monitoring
If the patient has an intra-arterial catheter, the adequacy of the 
compressions and the return of spontaneous circulation (ROSC) 
can be evaluated by observing the pressure waveform. Capnogra-
phy is also useful for evaluating the adequacy of the compressions 
and identifying ROSC.
3. Respiratory failure
Respiratory failure is a condition that indicates inadequate oxy-
genation and/or ventilation, and should be suspected if the fol-
lowing symptoms are observed. 
•  An increasing respiratory rate and signs of respiratory failure (e.g., 
nasal flaring, seesaw respirations, and moaning sounds)
•  An inadequate respiratory rate and respiratory effort, thoracic 
movement, reduced breath sounds, or breathlessness in patients 
with a reduced level of consciousness
•  Cyanosis while an external oxygen supply is being provided
4. Shock
Hypotension does not develop during the early phase of shock, 
which is also called compensated shock or normal pressure shock. 
Compensated shock presents as tachycardia, cool and pale ex-
tremities, a>2 seconds delay in the capillary refill time, a weak 
peripheral pulse with a maintained central pulse, and a normal 
blood pressure. If the compensation mechanisms fail, it can result 
in hypoperfusion of the major organs, reduced consciousness, re-
duced urine output, metabolic acidosis, tachypnea, weak central 
pulses, and a change in skin color.
 Cardiac output is the product of heart rate and stroke volume. 
If the stroke volume is decreased due to any cause, the heart rate 
increases to compensate for the decrease in cardiac output. Sus-
tained sinus tachycardia without other causes can be the first sign 
of shock, although bradycardia can develop after shock has pro-
gressed. Reductions in cardiac output and poor perfusion can de-
crease the peripheral pressure (intensity or quality), prolong the 
capillary refill time, and lower the skin temperature despite a warm 
surrounding temperature. However, the blood vessels of the skin 
and muscles are inadequately dilated during early septic shock, 
and the patient may exhibit a palpable peripheral pulse and rela-
tively high skin temperature, despite being in shock. 
 The criteria for hypotension in infants and children during CPR are: 
•  Full-term infants (0 to 28 days old): a systolic pressure of <60 
mmHg
•  Infants (1 to 12 months old): a systolic pressure of <70 mmHg
•  Children (1 to 10 years old): a systolic pressure of less than (70+ 
[2×age in years]) mmHg
•  Children (>10 years old): a systolic pressure of <90 mmHg
 These blood pressure criteria are below the fifth percentiles for the 
age-specific systolic pressures, and rarely occur in normal children.
ADVANCED AIRWAY 
1. Bag-mask ventilation
Bag-mask ventilation is relatively effective and safe in cases of 
out-of-hospital CPR, compared to endotracheal intubation.5 Select 
an adequate size of mask, open the airway properly, completely 
attach the mask to the face, and maintain a sufficient respiratory 
rate and pressure to ensure that the chest rises properly. Hyper-
ventilation can reduce blood flow to the brain and heart, as it in-
creases intrathoracic pressure, reduces venous return, and reduces 
cardiac output.6 In addition, hyperventilation can cause air trap-
ping in patients with peripheral airway collapse and barotrauma. 
Excessive inspiratory pressure can cause gastric inflation, which 
can lead to reflux of the stomach contents and pulmonary aspira-
tion. In infants and children without an inserted advanced airway, 
perform two breaths after every 30 compressions (or after every 
15 compressions if there are two rescuers). Stop compressions 
during the breathing, which should be performed for approxi-
mately 1 second per breath. Breaths should be performed every 6 
seconds (10 per minute) without interruption of the compressions 
if an advanced airway is inserted. Perform breathing only every 3 
to 5 seconds (12 to 20 per minute) if ROSC is achieved but respi-
ration is inadequate. The ventilation rate should be increased 
when the patient is young.
2. Two-person bag-mask ventilation 
Perform two-person bag-mask ventilation when there are two 
rescuers. This technique is especially helpful when a patient has 
airway collapse or low pulmonary compliance, or when the rescuer 
cannot completely attach the bag to the patient’s face.7 During 
two-person bag-mask ventilation, one rescuer holds the mask to 
the face while lifting the patient’s chin with both hands, while the 
other rescuer compresses the bag. Both rescuers should frequently 
confirm that the patient’s chest is expanding properly.
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3. Endotracheal intubation
Significant training is needed to successfully perform endotracheal 
intubation in infants and children, because they have a unique 
tracheal structure. Compared to adults, children’s tongues are rel-
atively large, their airways are more flexible, the tip of their epi-
glottis is located at a relatively high and anterior portion of the 
neck, and their airway is smaller.
1) Size of the pediatric endotracheal tube
Among children who weigh <35 kg, even with a relatively short 
stature, determining the endotracheal tube (ETT)’s size based on 
height is more accurate than using their age (e.g., using a Brosel-
ow resuscitation tape).8,9 However, also prepare tubes that are 0.5 
mm larger and smaller in internal diameter (ID) than the calculat-
ed tube size, regardless of the presence or absence of a cuff. If re-
sistance is felt during the intubation, use the 0.5 mm smaller tube. 
If there is significant air leakage at the glottis, the 0.5 mm larger 
tube or a cuffed tube should be used. For an un-cuffed tube, use a 
tube with an ID of 3.5 mm for infants who are <1 year old, and a 
4.0-mm tube for children who are 1 to 2 years old. For children 
who are >2 years old, use the following formula: ID of the un-
cuffed tube (in mm)=4+(age in years/4). If a cuffed tube must be 
used in an emergency, use a tube with an ID of 3.0 mm for chil-
dren who are <1 year old, and a 3.5 mm tube for children who 
are 1 to 2 years old. For children who are >2 years old, use the 
following formula:10-13 ID of the cuffed tube (in mm)=3.5+(age in 
years/4).
2) Cuffed ETT
Both cuffed and un-cuffed tubes can be used for endotracheal in-
tubation in infants and children. If a cuffed tube is used during 
surgery, the frequency of reintubation can be reduced without an 
increased risk of complications.10 Using a cuffed tube in the inten-
sive care unit (ICU) can reduce the risk of aspiration.14 If a cuffed 
tube is used, the cuff’s pressure should be constantly monitored 
and the manufacturer’s recommended pressure should be main-
tained (usually <20 to 25 cmH2O). A cuffed tube can be more ef-
fective if it is selected based on the size, location, and pressure of 
the cuff in cases with low pulmonary compliance, high airway re-
sistance, or significant air leakage at the glottic area.15,16
3) Endotracheal intubation
Prepare a suction catheter, bag-mask, oxygen, and stylet before 
the intubation. The tip of the stylet should not pass the tip of the 
tube. Applying a water-based lubricant or sterile distilled water to 
the tip of the stylet may make it easier to remove after the intu-
bation. Also prepare a functioning laryngoscope handle, blades, an 
extra light bulb, extra batteries, capnometry, tape to fix the tube, 
and gauze to clean the patient’s face.
 Perform endotracheal intubation after oxygen administration 
unless the patient is in cardiac arrest. Assisted ventilation can be 
performed if the patient’s respiratory effort is insufficient. It should 
be performed with the preparation of a secondary method for 
maintaining the airway, in anticipation of intubation failure. Im-
mobilize the cervical vertebrae to prevent spinal injury during the 
intubation in cases that involve severe trauma to the head, neck, 
or other areas. The procedure duration should not exceed 30 sec-
onds, as hypoxia or ischemic injury can occur due to inadequate or 
delayed intubation. Monitor the patient’s heart rate and oxygen 
saturation (using pulse oximetry) while performing endotracheal 
intubation. Stop the procedure and wait until the patient’s condi-
tion improves, while providing oxygen using a bag-mask, if the 
patient develops bradycardia (<60/min), a change in skin color or 
blood circulation status, or oxygen saturation below the normal 
level. In cases of pediatric cardiac arrest, the endotracheal intuba-
tion should not be delayed to set up pulse oximetry, which cannot 
function properly if the pulse is not palpable.
 Use either straight or curved laryngoscope blades. Once the tip 
of a straight blade passes the epiglottis, place it at the entrance of 
the vocal cords, lift the base of the tongue, and swipe the blade 
anteriorly to lift the epiglottis. If a curved blade is used, anteriorly 
adjust the location of the tongue’s base after the tip of the blade 
is placed in the epiglottic vallecula. At that point, the laryngoscope 
blade or handle should not be used as a lever, and direct pressure 
on the lips or gum should be avoided.
 The glottis entrance should be exposed for ideal endotracheal 
intubation. To simplify the intubation in infants and children, align 
the pharynx by placing a pillow under the patient’s head with the 
chin in the sniffing position. For infants or children who are <2 
years old, it is acceptable to lay them flat without a pillow to per-
form intubation through the mouth.
 The depth of the ETT intubation can be calculated using the fol-
lowing formula: intubation depth (in cm) =the tube’s ID (in 
mm)×3. For children who are >2 years old, the formula is: intu-
bation depth (in cm)=(the child’s age in years/2)+12.
4) Checking the tube’s location
The correct location of the tube cannot be verified using only clin-
ical signs such as chest wall movement or vapor inside the tube. 
The tube’s location should be checked immediately after intuba-
tion, re-fixing the tube, transfer, and patient movement. The signs 
of a correct tube location are:
•  Movement of the bilateral chest wall and symmetrical breathing 
sounds in both lungs, and particularly in the axillary areas
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•  The absence of gastric inflation sounds
•  Appropriate end-tidal CO2 (end-tidal carbon dioxide, ETCO2)
•  Adequate oxygen saturation while perfusion is maintained. How-
ever, oxygen saturation can be maintained for approximately 3 
minutes after hyperoxygenation despite poor ventilation
•  Laryngoscopic evidence that the tube is placed between the vo-
cal cords
•  Chest radiography findings that confirm the tube is correctly lo-
cated
 For immobilization of the tube, the tube should be fixed in a 
neutral position to prevent the tube from sliding deeper if the pa-
tient’s neck flexes, or sliding out if the patient’s neck extends.17 If 
the patient’s condition suddenly deteriorates while they are intu-
bated, determine whether the tube is displaced or occluded, pneu-
mothorax is present, or a mechanical error has occurred. 
5) Capnometry or capnography
If possible, verify the location of the ETT using capnometry for all 
age groups and in all circumstances, including in the pre-hospital, 
emergency room, ICU, ward, operation room, or transfer set-
tings.16-18 However, this method cannot detect whether a tube is 
placed in the right main bronchus, despite the appearance of color 
changes or the proper waveform. Because ETCO2 may not be de-
tected during cardiac arrest, even if the tube is properly located, 
the tube’s location must be checked using a laryngoscope.
•  If the capnometry is contaminated by gastric contents or an 
acidic drug, the color persists as the acidic color and does not 
accurately reflect the ventilation
•  When epinephrine is intravenously infused, pulmonary perfusion 
is temporarily reduced and the ETCO2 value can decrease below 
the critical value18
•  If there is severe airway occlusion, such as moderate asthma or 
pulmonary edema, the exhalation of CO2 can decrease below the 
critical value19
•  In cases with air leakage at the glottis region, the CO2 is diluted 
and may not be detected, due to the insufficient ventilation
DRUGS THAT ARE USED FOR PALS (Table 1)
1. Adenosine
Adenosine temporarily blocks atrioventricular (AV) node conduc-
tion and interrupts the re-entrant mechanism. The half-life of ad-
enosine is very short, which gives it a broad safety range. Large 
doses should be administered through a peripheral vein compared 
to a central vein, although adenosine can be also administered in-
traosseously. Additional normal saline should be provided immedi-
ately after an intravenous (IV) infusion of adenosine to help the 
adenosine rapidly enter the central circulation.
Table 1. Drugs used in pediatric advanced life support  
Medication Dose Remarks 
Adenosine 0.1 mg/kg (maximum 6 mg) Monitor ECG
Rapid IV/IO bolus with flush
Amiodarone 5 mg/kg IV/IO; may repeat twice up to 15 mg/kg
Maximum single dose 300 mg
M onitor ECG and blood pressure; adjust administration rate to urgency (IV 
push during cardiac arrest, more slowly over 20 to 60 minutes with 
perfusing rhythm). Expert consultation strongly recommended prior to 
use when patient has a perfusing rhythm. Use caution when adminis-
tering with other drugs that prolong QT (obtain expert consultation)
Atropine 0.02 mg/kg IV/IO
0 .04 to 0.06 mg/kg ET (flush with 5 mL of normal saline and follow with 
5 ventilations.)
Maximum single dose: 0.5 mg
Higher doses may be used with organophosphate poisoning
Calcium chloride (10%) 20 mg/kg IV/IO, Maximum dose 2 g Administer slowly
Epinephrine 0.01 mg/kg (0.1 mL/kg 1:10,000) IV/IO
0 .1 mg/kg (0.1 mL/kg 1:1000) ET (flush with 5 mL of normal saline and 
follow with 5 ventilations)
Maximum dose 1 mg IV/IO; 2.5 mg ET
May repeat every 3 to 5 minutes
Glucose 0.5 to 1 g/kg IV/IO Newborn: 5 to 10 mL/kg D10W
Infants and children: 2 to 4 mL/kg D25W
Adolescents: 1 to 2 mL/kg D50W
Lidocaine Bolus: 1 mg/kg IV/IO
Infusion: 20 to 50 µg/kg/min
Magnesium sulfate 25 to 50 mg/kg IV/IO over 10 to 20 minutes, faster in torsades de pointes
Maximum dose 2 g 
Sodium bicarbonate 1 mEq/kg per dose IV/IO slowly After adequate ventilation 
ECG, electrocardiography; IV, intravenous; IO, intraosseous; ET, endotracheal; D10W, 10% dextrose; D25W, 25% dextrose; D50W, 50% dextrose.  
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2. Amiodarone
Amiodarone delays conduction in the AV node, prolongs the re-
fractory period and QT interval, and slows ventricular conduction. 
However, amiodarone should be infused as slowly as the patient’s 
condition allows, and their blood pressure should be monitored. 
The appropriate infusion rate is relatively slow if there is a pulse, 
and is relatively fast in cases of cardiac arrest or VF. Hypotension 
can develop due to vasodilation during the administration, and its 
magnitude is related to the administration rate. This effect is less 
frequent when amiodarone is administered as a liquid form.20 An 
electrocardiogram (ECG) should be used to monitor for adminis-
tration-related complications, such as bradycardia, AV block, and 
torsades de pointes. Special care should be taken during the coad-
ministration of other medications that can prolong the QT interval. 
The half-life of amiodarone can reach 40 days, so any related ad-
verse effect(s) may last a prolonged duration.
3. Atropine
As a parasympathetolytic agent, atropine increases cardiac rhythm 
and AV conduction. Atropine is administered as an IV or intraosse-
ous (IO) infusion, with no minimum dose, in pediatric cases with a 
risk of severe bradycardia during emergency endotracheal intuba-
tion. However, routine atropine administration is not recommend-
ed for infants and children if emergency endotracheal intubation 
is necessary.21-23 Large doses of atropine should be administered in 
cases of nerve gas poisoning or organophosphate poisoning.24
4. Calcium
The routine administration of calcium during cardiac arrest does 
not improve the patient’s prognosis, and routine administration is 
not recommended as life support for patients who are in asysto-
le.3,25,26 Calcium is used to treat proven hypocalcemia or hyperka-
lemia, especially in patients with hemodynamic dysfunction. A de-
crease in the levels of ionized calcium is relatively common in se-
verely ill children, and especially in children with sepsis. Calcium 
should be considered for treating hypermagnesemia or overdose 
with a calcium channel blocker. The most common formation of 
calcium for children is 10% calcium chloride, as it has a higher 
bioavailability than calcium gluconate, and this solution should be 
infused through a central vein due to the risk of peripheral vein 
injury.27,28 An IV infusion of calcium should be administered over 
10 to 20 seconds for patients in cardiac arrest and over 5 to 10 
minutes for patients with a perfusing rhythm.
5. Epinephrine
Epinephrine is an intrinsic catecholamine that strongly stimulates 
the alpha and beta adrenergic receptors of the sympathetic nerves. 
Epinephrine’s most significant pharmacological action during car-
diac arrest is vasoconstriction caused by activation of alpha adren-
ergic receptors. This increases the aortic diastolic pressure and the 
perfusion pressure in the coronary artery, which is a significant de-
terminant of successful CPR.29,30 During compressions, the in-
creased perfusion pressure in the coronary artery increases the ox-
ygen supply to the heart. Epinephrine also improves the rate of 
successful defibrillation by increasing the VF amplitude and myo-
cardial contraction, which stimulates spontaneous contraction.
 The most common rhythms during pediatric cardiac arrest are 
asystole and bradycardia, and epinephrine can provide a perfusing 
rhythm in these patients. The epinephrine can be administered us-
ing an IV/IO infusion, or through the ETT in pediatric patients with 
symptomatic bradycardia who do not respond to effective assisted 
ventilation or oxygen supply. However, it is important to monitor 
the oxygen supply and circulation, because catecholamine activity 
can be reduced by acidosis or hypoxia. If the initial dose of epi-
nephrine is not effective, it should be repeatedly administered ev-
ery 3 to 5 minutes during CPR.
 Although epinephrine can be absorbed when it is administered 
using an ETT, the absorbed amount and serum concentration can-
not be predicted. Therefore, a continuous IV infusion of epinephrine 
can be helpful once ROSC is achieved. Epinephrine’s hemodynamic 
effects are related to its dosage, with low doses (<0.3 μg/kg/min) 
prominently resulting in beta adrenergic activity and higher doses 
(>0.3 μg/kg/min) predominantly causing vasoconstriction due to 
both beta and alpha adrenergic activities. It is preferable to admin-
ister epinephrine via the central circulation, as extravasation of 
epinephrine can lead to local ischemia, tissue damage, and necro-
sis. Similar to other catecholamines, epinephrine is inactivated in 
alkali solutions and should not be mixed with sodium bicarbonate. 
Epinephrine can be administered during CPR for infants and chil-
dren who are in cardiac arrest, although there is insufficient evi-
dence regarding the effects of other vasopressors.31-34
6. Glucose
Infants have low stored levels of glucose, and a high demand for 
glucose. Furthermore, infants can readily develop hypoglycemia if 
they have a condition that requires an increased energy supply 
(e.g., shock). Therefore, glucose levels should be closely monitored 
using a rapid bedside test in cases of coma, shock, or respiratory 
failure. Once hypoglycemia has been confirmed, it should be 
treated using a glucose-containing fluid.35 Two to four milliliters 
of 25% glucose solution (250 mg/mL) per kilogram provides 0.5 to 
1.0 g/kg of glucose, and 5 to 10 mL of a 10% glucose solution (100 
mg/mL) also provides a similar amount of glucose. It is preferable 
to treat hypoglycemia using a continuous infusion of a glucose 
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solution, as osmotic diuresis can be caused by a sudden increase 
in the plasma oncotic pressure after a single administration of a 
hypertonic glucose solution. The current recommendation is to 
maintain euglycemia during the CPR and to prevent hypoglycemia 
after the CPR, as there are no data regarding whether hyperglyce-
mia is advantageous or harmful after cardiac arrest.
7. Lidocaine
Lidocaine reduces myocardial automaticity and prevents ventricu-
lar arrhythmia. But it can depress the myocardium, and reduces 
circulation, causing drowsiness, disorientation, muscle twitching, 
and seizure. Amiodarone and lidocaine can be used in infants and 
children with VF and pulseless VT that does not respond to defi-
brilaltion.22,36,37 Nevertheless, there is a significant possibility of 
adverse effect(s) in cases with a low cardiac output, abnormal he-
patic function, or abnormal renal function.38,39
8. Magnesium
Magnesium is only administered to patients with proven hypo-
magnesemia and torsade de pointes.40-42 A rapid IV infusion (for a 
few minutes) of magnesium sulfate is recommended for torsade 
de pointes, regardless of its cause. Magnesium causes vasodila-
tion, and hypotension can develop when it is rapidly infused.
9. Sodium bicarbonate
In most studies, the routine administration of sodium bicarbonate 
has not improved the post-arrest prognosis.43,44 Adequate ventila-
tion, oxygen supply, and effective recovery of systemic perfusion 
(to correct tissue ischemia) should be the primary concerns in pe-
diatric cardiac arrest, because respiratory failure is an important 
cause in these cases. Once effective ventilation has been con-
firmed, and epinephrine with compressions has been started to 
maximize circulation, the administration of sodium bicarbonate 
can be considered in cases of a prolonged cardiac arrest. Sodium 
bicarbonate is also recommended for patients with symptomatic 
hyperkalemia, hypermagnesemia, and overdose with tricyclic anti-
depressants or other sodium channel blockers.
 If indicated, sodium bicarbonate is administered as an IV or IO 
infusion, and a diluted solution can be used to prevent increased 
oncotic pressure in neonates, although there is no evidence that a 
diluted solution is beneficial in infants or children. The appropriate 
dose of sodium bicarbonate can be determined using blood gas 
analysis. Because catecholamines are inactivated by sodium bicar-
bonate, and calcium forms a precipitate when it is mixed with so-
dium bicarbonate, 5 to 10 mL of normal saline should be used to 
flush the IV line after administering sodium bicarbonate.
10. Vasopressin
Vasopressin is an intrinsic hormone that activates a specific recep-
tor and mediates systemic vasoconstriction or water reabsorption 
in renal tubules. There is insufficient data to determine whether 
the routine use of vasopressin can be recommended in cases of 
pediatric cardiac arrest. Vasopressin or terlipressin (a long-acting 
drug) can be effective in children or adults who have failed stan-
dard treatment for cardiac arrest.45-47
TREATMENT FOR PULSELESS ARREST 
If a child is unresponsive and breathless, the responder should im-
mediately start high-quality CPR, supply oxygen (if possible), and 
ask someone to bring a defibrillator. An ECG monitor or automated 
external defibrillator (AED) electrodes should be attached as soon 
as possible. Cardiac rhythm is monitored using an ECG monitor 
during CPR for children, although an AED will automatically notify 
the rescuer if the patient has a shockable rhythm (VF or pulseless 
VT) or a non-shockable rhythm (asystole or pulseless electrical ac-
tivity [PEA]). Temporarily interrupting the compressions may be 
necessary to check the rhythm. Asystole or wide QRS bradycardia 
is the most common rhythms during asphyxial cardiac arrest. Al-
though VF or PEA does not frequently occur in infants or children, 
there is a high probability of VF-induced cardiac arrest in cases of 
sudden witnessed cardiac arrest among older children (Fig. 1).
1. Non-shockable rhythm (asystole/PEA)
The definition of PEA is the presence of organized electrical activi-
ty, such as a slow and wide QRS, without a palpable pulse. There 
can be a normal heart rate without a pulse and with poor tissue 
perfusion during the early stage of suddenly impaired cardiac out-
put. This condition is more reversible than asystole and used to be 
known as electromechanical dissociation.
 Minimize any interruption in the compressions and continue 
CPR. The second rescuer should establish an IV or IO line and ad-
minister epinephrine at 0.01 mg/kg (0.1 mL/kg in a 1:10,000 solu-
tion) during the CPR, and the same dose should be administered 
every 3 to 5 minutes. High-dose epinephrine does not improve the 
survival rate, and can cause harm, although it may be considered 
in exceptional cases, such as cases of overdose with beta block-
ers.32,48
 If an advanced airway has been placed, the first rescuer should 
perform constant compressions at a rate of ≥100 to 120 per min-
ute, and the second rescuer should provide breaths every 6 seconds 
(approximately 10 per minute). The rescuer(s) who are performing 
the compressions should switch approximately every 2 minutes, 
while minimizing the interruption, to provide optimal compression 
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quality and rate, and to avoid compression-induced fatigue. During 
this period, the rhythm should be monitored while minimizing any 
interruption of the compressions. If the rhythm is non-shockable, 
CPR should be continued with epinephrine administration until 
there is evidence of ROSC or a decision is made to cease CPR. If 
the rhythm changes to a shockable rhythm, immediate compres-
sions and defibrillation should always be performed, and the rhythm 
should be rechecked after 2 minutes of CPR. The period between 
stopping or restarting the compressions and the defibrillation should 
be minimized. Find reversible cause(s) and correct them. 
2. Shockable rhythm (VF/pulseless VT)
Defibrillation is the most important treatment for VF, and provides 
an overall survival rate of approximately 17% to 20%.49 The re-
sulting survival rate is higher for primary VF, compared to second-
ary VF, and the survival rate after adult cardiac arrest decreases by 
7% to 10% for every 1-minute delay in starting CPR and defibril-
lation.50 The survival rate is highest when high-quality CPR is per-
formed with minimal interruptions during the early stage of cardi-
ac arrest. The output of defibrillation is better when the rescuer 
minimizes the time between the compressions and defibrillation.
DEFIBRILLATORS
As AEDs can detect the pediatric heart rhythm, they should be install-
ed in facilities that treat children with a risk of arrhythmia or cardiac 
arrest. The ideal defibrillator can adjust the energy dose for children.
1. Electrode size
A manual defibrillator typically has different sizes of electrodes for 
adults and children, and some manual defibrillators have self-ad-
hesive electrodes. In pediatric cases, the largest appropriate elec-
trode should be selected based on the patient’s chest size. The 
electrodes should not contact each other, and the space between 
the two electrodes should ≥3 cm. Self-adhesive electrodes should 
be completely attached to the patient’s chest by firmly pressing 
them onto the chest. The adult size of electrodes (8 to 10 cm) is 
used for children who are ≥1 year old or weigh ≥10 kg, and the 
pediatric size is used for infants who are <1 year old or weigh 
<10 kg.
2. Interface
Self-adhesive electrodes have pre-applied electrode gel on the in-
terface that should be placed on the patient’s chest. However, 
electrode gel must be applied for manual electrodes. Normal sa-
line, ultrasound gel, or alcohol are not appropriate replacements 
Fig. 1. Algorithm of pediatric cardiac arrest. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless 
electrical activity; IO, intraosseous; IV, intravenous; ROSC, return of spontaneous circulation.
Pediatric cardiac arrest
Shout for help/activate emergency response 
Request monitor/defibrillator
Start CPR
Attach monitor/defibrillator
Rhythm shockable?
VF/pulseless VT Asystole/PEA
Pulse present
(ROSC)
Lidocaine or 
amiodarone
Shock
CPR 2 minutes
Advanced airway
IO/IV access and epinephrine
CPR 2 minutes
Advanced airway
IO/IV access and epinephrine
Post-cardiac arrest care
S55Clin Exp Emerg Med 2016;3(S):S48-S61
Do Kyun Kim, et al.
for electrode gel.
3. Electrode placement
The manufacture’s recommendations should be followed when 
placing self-adhesive electrodes of an AED or monitor/defibrillator. 
Manual electrodes are placed at the apex (at the left lower rib, 
lateral to the left nipple) and the right upper quadrant of the 
chest, which locates the heart between the electrodes. The elec-
trodes must be firmly applied to maintain a strong contact, and 
there is no benefit to placing the electrodes on the anterior and 
posterior sides of the patient’s trunk. 
4. Energy dose
The lowest energy dose for effective defibrillation and the upper 
limit for safe defibrillation in infants or children are unknown. The 
first recommended energy dose is 2 to 4 J/kg for monophasic or 
biphasic defibrillators if the infant or child exhibits VF or pulseless 
VT. The second recommended dose is 4 J/kg, and any subsequent 
dose should never exceed the maximum adult dose.50,51 If there is 
no exact energy dose meter on the defibrillator, use the next high-
est energy on the energy selector when escalating the dose.52-54
5. AEDs
VF can be accurately detected by most AEDs in children of all 
ages. If the AED does not have an energy attenuating device, a 
manual defibrillator is preferred for children who are <1 year old. 
An AED with an energy attenuating device can be used unless a 
manual defibrillator is available. If both an AED with an energy at-
tenuating device and a manual defibrillator are unavailable, an 
AED without an energy attenuating device can be used in children.
6. Integrating defibrillation and CPR
CPR should be performed until the defibrillator is prepared and 
defibrillation is feasible, and the compressions should be re-started 
immediately after the defibrillation. It is ideal to only interrupt the 
compressions for checking cardiac rhythm, performing defibrilla-
tion, and breathing before placing an advanced airway. Once the 
rhythm has been evaluated, start and continue the compressions 
until the defibrillator is charged, even in cases with a shockable 
rhythm. The first defibrillation (2 to 4 J/kg) should be started as 
soon as possible, and CPR with compressions should be immedi-
ately re-started after the defibrillation. It is very important to min-
imize the interval between starting or stopping the compressions 
and the defibrillation. Continue CPR for approximately 2 minutes, 
although this sequence may be changed based on an expert’s 
opinion if the environment can facilitate continuous invasive 
monitoring (e.g., in a hospital). An IV or IO line can be established 
if there are enough rescuers. Rhythm should be checked after 2 
minutes of CPR, and the defibrillator should be charged at 4 J/kg. 
If a shockable rhythm persists, defibrillation should be applied at 4 
J/kg, and the algorithm for asystole/PEA should be followed if a 
non-shockable rhythm is observed. Resume the compressions im-
mediately after the second defibrillation, and continue CPR for ap-
proximately 2 minutes. Epinephrine should be administered at 0.01 
mg/kg (0.1 mL/kg in a 1:10,000 solution) every 3 to 5 minutes dur-
ing the CPR. If there is a third rescuer, epinephrine should be pre-
pared before checking the rhythm and administered as soon as 
possible. The rescuer who is in charge of the defibrillator should 
prepare the third defibrillator charge before checking the ECG 
rhythm (>4 J/kg and <10 J/kg or the maximum adult dose). If 
there is a shockable rhythm, an additional defibrillation should be 
administered (>4 J/kg and <10 J/kg or the maximum adult dose), 
and CPR should be immediately resumed. If the defibrillation is 
unsuccessful, amiodarone or lidocaine should be administered 
while continuing the CPR. The algorithm for pulseless cardiac ar-
rest is always followed if there is a non-shockable rhythm. If an 
advanced airway is placed, one rescuer should continue compres-
sions at a rate of ≥100 to 120 per minute, and the second rescuer 
should perform breathing every 6 seconds (10 per minute). If there 
are two or more rescuers, they should switch every 2 minutes to 
prevent compression-induced fatigue and to maintain adequate 
compression rate and quality. If there is an organized rhythm at 2 
minutes after the defibrillation, check the pulse to determine 
whether it is a perfusing rhythm. ROSC is predicted if the ETCO2 
rapidly increases during the compressions or the monitored arterial 
waveform increases. If both ROSC and a pulse are achieved, post-
CPR management can be started. However, if VF re-develops after 
successful defibrillation, CPR should be re-started and defibrilla-
tions should be attempted with the dose which achieved success-
ful defibrillation. Find and correct any other reversible causes.
MANAGEMENT OF TORSADE DE POINTES
Torsade de pointes is polymorphic VT and is associated with a pro-
longed QT interval. A prolonged QT interval can develop due to 
congenital conditions or drug toxicity, and is associated with class 
1A antiarrhythmic drugs (procainamide, quinidine, and disopyra-
mide), class III antiarrhythmic drugs (sotalol and amiodarone), tri-
cyclic antidepressants, digoxin, and drug interactions.55,56 Torsade 
de pointes typically progresses to VF or pulseless VT. Therefore, if 
pulseless cardiac arrest develops, the rescuer must start CPR and 
perform defibrillation. Regardless of the cause, magnesium (at 25 
to 50 mg/kg to a maximum dose of 2 g) should be rapidly admin-
istered over a few minutes as an IV infusion.
S56 www.ceemjournal.org 
Part 6. Pediatric advanced life support
POST-CPR MANAGEMENT
Post-CPR management should begin immediately after ROSC in 
patients who had shock, respiratory failure, and cardiac arrest. The 
purposes of post-CPR management are to: (1) maintain brain 
function, (2) avoid secondary organ damage, (3) correct the 
cause(s) of the cardiac arrest, and (4) prepare for the next treat-
ment step with an optimal hemodynamic status. Because the pa-
tient’s condition can deteriorate after a short period of temporary 
stabilization, the patient should be frequently monitored. Thor-
oughly determine whether the airway is secure, oxygen is supplied, 
and ventilation and perfusion are stabilized. Look for evidence of 
trauma and reevaluate the patient’s neurological condition during 
the examination. Check for any history of allergy, disease, medica-
tion, or vaccination, and evaluate the patient’s renal and hepatic 
functions (dysfunction can indirectly affect the patient’s prognosis).
1. Management of the respiratory system 
After children have received CPR, oxygen should be supplied until 
adequate oxygenation and proper oxygen carrying capacity is 
achieved, as measured using pulse oximetry or direct arterial blood 
gas analysis. High-dose oxygen should be administered if there are 
symptoms of significant respiratory distress (e.g., anxiety, breath-
ing impairment, cyanosis, or hypoxemia), and endotracheal intu-
bation with mechanical ventilation can be performed. If the intu-
bated patient experiences a sudden deterioration, consider the 
possibility of displacement or obstruction of the ETT, pneumotho-
rax, or mechanical errors. Analgesics or sedatives can be used for 
anxious patients if these factors are confirmed to be absent. How-
ever, careful attention is warranted, as seizures can be masked by 
the use of a neuromuscular blocker.
 A target arterial CO2 partial pressure can be established and 
maintained based on the patient’s specific condition after ROSC is 
achieved. There is no evidence that hypercapnia or hypocapnia are 
more beneficial than eucapnia for improving the patient’s survival 
rate and quality of life.57,58 Oxygen should be supplied to provide 
proper oxygenation for intubated patients, and the respiratory rate 
should be maintained at 30 to 40 per minute for infants and 20 to 
30 per minute for children. A sufficient tidal volume will cause the 
chest to visibly rise. Once mechanical ventilation is started, the 
tidal volume should be maintained at 6 mL/kg, which should cause 
the chest to visibly rise and yield respiratory sounds at the periph-
ery of the lung that can be detected using auscultation. A value of 
approximately 3 to 6 cmH2O should be used for positive end-expi-
ratory pressure, although a higher value can be used if the func-
tional residual capacity is reduced and the lung has collapsed.
 Arterial blood gas analysis should be performed at 10 to 15 min-
utes after early mechanical ventilation, and it is recommended that 
normal arterial oxygen partial pressure be maintained unless there 
is a specific reason for deviation.57,59,60 Cardiac anomalies in chil-
dren should be evaluated via echocardiography immediately after 
CPR, as the proper oxygen saturation can vary based on the pa-
tient’s hemodynamic status and congenital heart disease(s). Naso-
gastric or orogastric tube insertion is needed, as gastric inflation 
can cause discomfort and ventilation impairment.
2. Cardiovascular management
Because circulatory failure can develop after recovery from cardiac 
arrest, continuous or frequent evaluation of the cardiovascular 
system should be performed to rapidly detect any decreased car-
diac output or the development of shock. Inadequate tissue perfu-
sion can result in a prolonged capillary refill time, a reduced or ab-
sent peripheral pulse, a change in consciousness, cold extremities, 
tachycardia, a decreased urine output, and hypotension. An insuf-
ficient administration of fluid after CPR can cause a reduction in 
the cardiac output or shock that develops secondary to the re-
duced peripheral vascular resistance and myocardial stunning.61
 Heart rate, blood pressure, and oxygen saturation should be 
constantly monitored after CPR, and blood pressure should be 
monitored using an intra-arterial catheter (if possible) in patients 
with cardiovascular dysfunction. Because hypotension can fre-
quently occur during the period of ROSC after CPR, and this con-
dition is associated with a poor prognosis, the systolic pressure 
should be maintained at or above the fifth age-specific percentile, 
and IV fluids or inotropic agents should be administered.62-64 Urine 
output is a significant indicator of internal organ perfusion, and 
should be monitored using a urine catheter in patients with he-
modynamic dysfunction. The IO route should be removed once a 
secure IV line is established.
3. Drugs to maintain cardiac output
Myocardial impairment and vascular instability frequently occur 
after recovery from cardiac arrest. After CPR, systemic and pulmo-
nary vascular resistance usually increase during the early phase, 
except in cases of septic shock. Cardiovascular function also con-
stantly changes after CPR, as it exhibits a hyperdynamic status 
during the early phase, which subsides towards a gradual weaken-
ing of cardiac function. Therefore, if abnormal cardiovascular 
function is observed or suspected after CPR, an adequate dose of 
vasoactive drug(s) should be administered to improve cardiac 
function and tissue perfusion. The selection and dose of the 
drug(s) should be based on the individual patient’s status, and 
should be administered using an accurate IV route.
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1) Epinephrine
Epinephrine is used to treat shock for any reason, which does not 
respond to fluid administration and exhibits extremely low sys-
temic perfusion. As a strong vasoconstrictor, epinephrine increases 
systemic vascular resistance and heart rate through its chrono-
tropic activity. Epinephrine can be administered during bradycar-
dia with hemodynamic changes that do not respond to oxygen 
and mechanical ventilation.
 Low-dose epinephrine (<0.3 µg/kg/min) works as a strong ino-
tropic agent and reduces systemic vascular resistance by activat-
ing beta adrenergic receptors. If the dose is increased to >0.3 µg/
kg/min, epinephrine exerts both an inotropic effect and increases 
systemic vascular resistance by activating the vascular alpha ad-
renergic receptors. As epinephrine’s effects vary according to the 
dose in different patients, the dose must be frequently adjusted to 
achieve its intended effect. Epinephrine is more effective than do-
pamine in patients with severe circulatory compromise, and espe-
cially in infants.65
2) Dopamine
Dopamine has beta and alpha sympathomimetic effects through a 
direct dopaminergic effect and an indirect stimulatory effect on 
norepinephrine secretion. The dose of dopamine must be fre-
quently adjusted when it is used to treat shock with low systemic 
vascular resistance and no response to fluid administration. Al-
though it barely affects the systemic hemodynamic status at low 
doses (0.5 to 2 µg/kg/min), dopamine typically increases the blood 
flow to the heart and intestine, and increases cardiac output and 
blood pressure in neonates.66 At doses of >5 µg/kg/min, dopa-
mine induces cardiac beta adrenergic receptor activity, which in-
duces the secretion of norepinephrine from the cardiac sympa-
thetic nerve. However, dopamine’s ability to stimulate myocardial 
and vascular contraction can be reduced in some cases, such as 
chronic heart failure patients with depletion of myocardial norepi-
nephrine, and infants who are <1 month old with incomplete de-
velopment of the cardiac sympathetic nerve. At doses of >20 µg/
kg/min, dopamine induces excessive vasoconstriction and reno-
vascular dilatation disappears. Therefore, epinephrine or dobuta-
mine are recommended in cases where >20 µg/kg/min of dopa-
mine would be needed to increase myocardial contraction. Dopa-
mine is a catecholamine that can be partially inactivated in alkali 
solutions, and should not be mixed with bicarbonate.67
3) Dobutamine
Dobutamine is a synthetic catecholamine that exerts relatively se-
lective effects on the beta-1 adrenergic receptor, and has minimal 
effects on the beta-2 adrenergic receptor. Therefore, dobutamine 
is a relatively selective inotrope that can increase myocardial con-
traction and reduce systemic vascular resistance.68 Dobutamine is 
effective for increasing cardiac output and blood pressure in in-
fants and children. In particular, dobutamine can be used to treat 
secondary reductions in cardiac output due to decreased myocar-
dial function, such as in the post-cardiac arrest situation. Tachy-
cardia and premature ventricular contractions can occur at high 
doses of dobutamine.
4) Norepinephrine
Norepinephrine is a neurotransmitter that is secreted from the 
sympathetic nerve, and is a strong inotrope that it works on the 
peripheral alpha and beta sympathetic nerves to induce strong 
myocardial and peripheral vascular contractions. The alpha sym-
pathomimetic effect is predominant at the standard dose. As nor-
epinephrine is a strong vasoconstrictor, it can be used to treat 
septic shock that does not respond to fluid infusion and exhibits 
low systemic vascular resistance, spinal shock, and anaphylaxis. 
The infusion rate may be adjusted according to the patient’s blood 
pressure and perfusion status.
5) Nitroprusside
Nitroprusside is a vasodilator that induces the local production of 
nitric oxide in all blood vessels. At the therapeutic dose, it has no 
direct effects on myocytes, and increases cardiac output by reduc-
ing the resistance of the systemic and pulmonary blood vessels. 
The combination of nitroprusside and inotropes can be used in pa-
tients with severe hypertension or reduced cardiac output due to 
reduced myocardial function and increased vascular resistance. 
However, it should not be used if the blood volume is reduced, as 
it can cause severe hypotension. Nitroprusside is rapidly metabo-
lized and should be constantly infused with a dextrose solution, 
and should not be mixed with normal saline. Levels of thiocyanate 
should be monitored in cases with prolonged use, and especially 
when the infusion rate is >2 µg/kg/min. 
6) Inodilators
Inodilators, such as amrinone and milrinone, are used for patients 
with reduced cardiac function or increased resistance of the sys-
temic and pulmonary blood vessels. Similar to vasodilators, inodi-
lators do not increase the myocardial oxygen demand, increase 
the cardiac output, and have minimal effect on the heart rate. Hy-
potension is not common if the circulating blood volume is ade-
quate, but can occur due to vasodilation if there is an inadequate 
circulating blood volume. Therefore, fluid administration may be 
necessary to counteract vasodilation after drug administration.69
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4. Nervous system management
The primary purpose of CPR is to maintain brain function, and care 
must be taken to prevent secondary damage to the nervous sys-
tem after CPR. Hyperventilation has a negative effect on the prog-
nosis of the nervous system, as it affects both cardiac function 
and cerebral perfusion. Short periods of intentional hyperventila-
tion are acceptable in cases with signs of brain herniation, such as 
a sudden increase in intracranial pressure, mydriasis without a 
light reflex, bradycardia, or hypertension. Target temperature 
management can be considered for unconscious infants or chil-
dren with ROSC after cardiac arrest. The body temperature should 
not be allowed to drop below 32°C, or to increase above 37.5°C, 
even if target temperature management is not performed.70-75 As 
fever has a negative effect on the recovery of brain function, it 
should be actively treated using an antipyretic drug and an exter-
nal cooling method. Tremors can occur at low temperatures, and 
can be prevented using a sedative. Neuromuscular blockade can 
be used if necessary, although it can mask a seizure, and continu-
ous electroencephalogram monitoring can be used to detect sei-
zures.76 Although an adequate cooling and rewarming method has 
not been established, the body temperature should not increase at 
a rate of >0.5°C every 2 hours, unless there is another reason for 
rapid rewarming.
5. Renal system management
The prerenal condition that is caused by dehydration or inade-
quate perfusion, and/or ischemic injuries in the kidney(s), can re-
duce urine output (infants and children: <1 mL/kg/hr, adolescents: 
<30 mL/hr). Avoid using drugs with renal toxicity until the pa-
tient’s renal function has been confirmed, and adjust the dose of 
drugs that undergo renal excretion.
6. Gastrointestinal system management
In cases with no bowel sounds, abdominal distention, or required 
mechanical ventilation, perform nasogastric or orogastric intuba-
tion to prevent or treat gastric inflation. However, nasogastric in-
tubation is prohibited in patients with facial injuries or basal skull 
fractures, because the tube can enter the cranium. 
7. Factors predicting prognosis
The survival rate is higher in cases with a pupillary reflex within 24 
hours after CPR, compared to that in cases that do not fulfill this 
criterion,3,77-80 and there are reports that a poor prognosis may be 
predicted by increased levels of neuron-specific enolase and S100 
calcium-binding protein B.78,81,82 Although there are no established 
predictors of neurological and survival outcomes in children with 
ROSC, these outcomes may be predicted by pupillary reflex, neuron-
specific enolase and S100 calcium-binding protein B levels. Fur-
thermore, electroencephalogram results within 7 days after cardiac 
arrest may help predict neurologic outcomes,76,80 but the outcomes 
cannot be predicted using only electroencephalogram results.
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